Literature DB >> 32260612

Layer-by-layer coating of alginate matrices with chitosan-alginate for the improved survival and targeted delivery of probiotic bacteria after oral administration.

Michael T Cook1, George Tzortzis, Vitaliy V Khutoryanskiy, Dimitris Charalampopoulos.   

Abstract

The oral administration of probiotic bacteria has shown potential in clinical trials for the alleviation of specific disorders of the gastrointestinal tract. However, cells must be alive in order to exert these benefits. The low pH of the stomach can greatly reduce the number of viable microorganisms that reach the intestine, thereby reducing the efficacy of the administration. Herein, a model probiotic, Bifidobacterium breve, has been encapsulated into an alginate matrix before coating in multilayers of alternating alginate and chitosan. The intention of this formulation was to improve the survival of B. breve during exposure to low pH and to target the delivery of the cells to the intestine. The material properties were first characterized before in vitro testing. Biacore™ experiments allowed for the polymer interactions to be confirmed; additionally, the stability of these multilayers to buffers simulating the pH of the gastrointestinal tract was demonstrated. Texture analysis was used to monitor changes in the gel strength during preparation, showing a weakening of the matrices during coating as a result of calcium ion sequestration. The build-up of multilayers was confirmed by confocal laser-scanning microscopy, which also showed the increase in the thickness of coat over time. During exposure to in vitro gastric conditions, an increase in viability from <3 log(CFU) per mL, seen in free cells, up to a maximum of 8.84 ± 0.17 log(CFU) per mL was noted in a 3-layer coated matrix. Multilayer-coated alginate matrices also showed a targeting of delivery to the intestine, with a gradual release of their loads over 240 min.

Entities:  

Year:  2012        PMID: 32260612     DOI: 10.1039/c2tb00126h

Source DB:  PubMed          Journal:  J Mater Chem B        ISSN: 2050-750X            Impact factor:   6.331


  7 in total

1.  Activation of a passive, mesoporous silica nanoparticle layer through attachment of bacterially-derived carbon-quantum-dots for protection and functional enhancement of probiotics.

Authors:  Hao Wei; Wei Geng; Xiao-Yu Yang; Jeroen Kuipers; Henny C van der Mei; Henk J Busscher
Journal:  Mater Today Bio       Date:  2022-05-17

2.  Layer-by-Layer Coating of Single-Cell Lacticaseibacillus rhamnosus to Increase Viability Under Simulated Gastrointestinal Conditions and Use in Film Formation.

Authors:  Maram Sbehat; Mohammad Altamimi; Mohammad Sabbah; Gianluigi Mauriello
Journal:  Front Microbiol       Date:  2022-05-04       Impact factor: 6.064

3.  Formulation of Isopropyl Isothiocyanate Loaded Nano Vesicles Delivery Systems: In Vitro Characterization and In Vivo Assessment.

Authors:  Chandra Kala; Mohammad Asif; Sadaf Jamal Gilani; Syed Sarim Imam; Najam Ali Khan; Mohamad Taleuzzaman; Ameeduzzafar Zafar; Mohammed Muqtader Ahmed; Sultan Alshehri; Mohammed M Ghoneim
Journal:  Molecules       Date:  2022-04-30       Impact factor: 4.927

4.  Evaluation of Surface Modified Live Biotherapeutic Products for Oral Delivery.

Authors:  Ava M Vargason; Aaron C Anselmo
Journal:  ACS Biomater Sci Eng       Date:  2020-12-30

5.  Upconversion optogenetic micro-nanosystem optically controls the secretion of light-responsive bacteria for systemic immunity regulation.

Authors:  Chun Yang; Meihui Cui; Yingying Zhang; Huizhuo Pan; Jing Liu; Shixing Wang; Ning Ma; Jin Chang; Tao Sun; Hanjie Wang
Journal:  Commun Biol       Date:  2020-10-09

Review 6.  Intestinal Bacteria Encapsulated by Biomaterials Enhance Immunotherapy.

Authors:  Yilun Liu; Zhongmin Li; Yuanyu Wu; Xiabin Jing; Lin Li; Xuedong Fang
Journal:  Front Immunol       Date:  2021-02-10       Impact factor: 7.561

7.  Development of chitosan-coated agar-gelatin particles for probiotic delivery and targeted release in the gastrointestinal tract.

Authors:  Hanady A Albadran; Andrea Monteagudo-Mera; Vitaliy V Khutoryanskiy; Dimitris Charalampopoulos
Journal:  Appl Microbiol Biotechnol       Date:  2020-05-06       Impact factor: 4.813

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.